

Cover Story
Free
By Matthew Bin Han Ong
The power morcellator should no longer be used for hysterectomies or fibroid removal in the vast majority of women getting these procedures, FDA declared in a highly anticipated guidance document Nov. 24.
In Brief


Drugs & Targets
Trending Stories
- Pediatric cancer research cut from spending legislation at last minute
Republicans quietly removed hard-won pediatric cancer bills - Biden’s FY23 proposal cuts NCI funds by $199M, while boosting ARPA-H by $4B
- Trump et al. focus on NIH, cancer—and how peer review is done
- Fired NCI employee says Trump’s purge was baseless yet punitive
“I feel like I’ve been erased” - Bhattacharya provides calm answers to anxious questions at confirmation hearing
Trump nominee for NIH director calls for transparency, audits of indirect costs - Former CDER Director Patrizia Cavazzoni named Pfizer chief medical officer, executive vice president